Douglas S. Scherr, M.D.
Honors and Awards
William Beaumont Medical Research Honor Society
First Prize for Best Original Medical Essay, The William Shafirt Award, The George Washington University School of Medicine. A crisis of unknown proportion: An empirical analysis of the American medical malpractice system. 1994
First Prize for Clinical Investigation, Ferdinand C. Valentine Urology Residents Essay Meeting, BCL-2 and P53 expression in clinically localized prostate cancer as predictive markers for the response to external beam radiotherapy. 1998
First Prize for Clinical Investigation, Society of University Urology Residents, Annual Chief Resident Meeting, Marietta, Georgia. Anti-androgen therapy for prostate cancer and the prevention of osteoporosis: The role of DES. 2000
Second Prize for Clinical Investigation, Ferdinand C. Valentine Urology Residents Essay Meeting, Collagen Type I Crosslinked N-Telopeptide as a urinary marker for osteoporosis in prostate cancer: The role of Diethylstilbesterol (DES). 2000
Pfizer, Scholars in Urology Award, Awarded for advancing the scientific and clinical field of urology. 2000
Ferdinand C. Valentine Fellowship for Research in Urology. The New York Academy of Medicine. 2001-2002. Syndecan-1 expression in prostate cancer and the role of p27 in primary prostate epithelial cell transformation.
T32 Research Training Grant. Memorial Sloan Kettering Cancer Center. 2000-2002.
Edwin Beer Research Award. NY Academy of Medicine. Effective Tumor Immunotherapy in Transitional Cell Carcinoma of the Bladder. 2004-2006
Career Development Award. Kidney Urology Foundation of America. The role of the Pim-1 Oncoprotein in Prostate Carcinogenesis. 2004-2005